1625672-21-0

Basic information

• Product Name: 1-((4-cyanophenyl)(2-hydroxy-6-oxo-4-(thiophen-2-yl)cyclohex-1-enyl)methyl)-3-(3-(trifluoromethyl)phenyl)urea
• Synonyms: 1-((4-cyanophenyl)(2-hydroxy-6-oxo-4-(thiophen-2-yl)cyclohex-1-enyl)methyl)-3-(3-(trifluoromethyl)phenyl)urea
• CAS NO: 1625672-21-0
• Molecular Weight: 511.524
• Mol File: 1625672-21-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1-((4-cyanophenyl)(2-hydroxy-6-oxo-4-(thiophen-2-yl)cyclohex-1-enyl)methyl)-3-(3-(trifluoromethyl)phenyl)urea(CAS DataBase Reference)
• NIST Chemistry Reference: 1-((4-cyanophenyl)(2-hydroxy-6-oxo-4-(thiophen-2-yl)cyclohex-1-enyl)methyl)-3-(3-(trifluoromethyl)phenyl)urea(1625672-21-0)
• EPA Substance Registry System: 1-((4-cyanophenyl)(2-hydroxy-6-oxo-4-(thiophen-2-yl)cyclohex-1-enyl)methyl)-3-(3-(trifluoromethyl)phenyl)urea(1625672-21-0)

Safety Data

• Hazardous Substances Data: 1625672-21-0(Hazardous Substances Data)

Upstream product

• 23994-65-2 5-(2-thienyl)cyclohexane-1,3-dione 
• 13114-87-9 N-(3-trifluoromethylphenyl)urea 
• 105-07-7 4-cyanobenzaldehyde 

Relevant articles and documents

Substituted Bicyclic Dihydropyrimidinones And Their Use As Inhibitors Of Neutrophil Elastase Activity

This invention relates to substituted bicyclic dihydropyrimidinones of formula 1 and their use as inhibitors of neutrophil elastase activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of pulmonary, gastrointestinal and genitourinary diseases, inflammatory diseases of the skin and the eye and other autoimmune and allergic disorders, allograft rejection, and oncological diseases.